收藏切换
Efficacy and safety of recombinant human tumor necrosis factor receptor Ⅱ-immunoglobulin G-Fc fusion protein for injection combined with methotrexate for injection in the treatment of active rheumatoid arthritis
收藏切换
Xuemei ZHOU1, Xiangyun LU1, Hongda LIANG1, Xiaoqing WANG2, *
World Clinical Drug | 2023, 44(3) : 258 - 262
Less
收藏切换
World Clinical Drug | 2023, 44(3): 258-262
• Article •
Efficacy and safety of recombinant human tumor necrosis factor receptor Ⅱ-immunoglobulin G-Fc fusion protein for injection combined with methotrexate for injection in the treatment of active rheumatoid arthritis
Full
Xuemei ZHOU1, Xiangyun LU1, Hongda LIANG1, Xiaoqing WANG2, *
Affiliations
  • 1.Department of Rheumatology and Immunology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China
  • 2.Department of Rheumatology and Immunology, Gaomi People's Hospital, Weifang 261599, Shandong Province, China
Published: 2023-03-10 doi: 10.13683/j.wph.2023.03.010
Outline
收藏切换
Objective

To evaluate and compare efficacy and safety of recombinant human tumor necrosis factor receptor Ⅱ-immunoglobulin G-Fc fusion protein for injection (rhTNFR-Fc) combined with methotrexate (MTX) and MTX alone in the treatment of active rheumatoid arthritis (RA).

Methods

A total of 72 patients with active RA who visited department of rheumatology and immunology, Gaomi people's hospital from July 1, 2021 to July 1, 2022 were selected and divided into combination group and control group according to the order of treatment and random number table method, with 36 cases in each group. Both groups were given MTX orally and the combination group was given rhTNFR-Fc, all patients were treated for 24 weeks. Joint symptoms, inflammatory indicators, efficacy and adverse reactions were compared before and after treatment.

Results

After treatment, the levels of C-reactive protein (2.50 mg/L vs 6.35 mg/L) and erythrocyte sedimentation rate (20.50 mm/h vs 27.50 mm/h) decreased in the two groups, and the differences were statistically significant (P<0.05). There were significant differences in response rates of American College of Rheumatology (ACR)20 (88.89% vs 66.67%), ACR50 (75.00% vs 50.00%) and ACR70 (63.89% vs 38.89%) and disease activity score 28 (2.32 scores vs 2.74 scores) (P<0.05).

Conclusion

RhTNFR-Fc combined with MTX can reduce inflammatory indexes in RA patients with better effect and does not increase the incidence of adverse reactions. It has high safety and clinical application value, and is worthy of further promotion.

recombinant human tumor necrosis factor receptorⅡ-immunoglobulin G-Fc fusion protein for injection  /  methotrexate  /  rheumatoid arthritis  /  curative effect  /  security
周雪梅, 卢祥云, 梁宏达, 王晓庆. 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白联合甲氨蝶呤治疗活动性类风湿关节炎的效果及安全性研究. 世界临床药物, 2023 , 44 (3) : 258 -262 . DOI: 10.13683/j.wph.2023.03.010
Xuemei ZHOU, Xiangyun LU, Hongda LIANG, Xiaoqing WANG. Efficacy and safety of recombinant human tumor necrosis factor receptor Ⅱ-immunoglobulin G-Fc fusion protein for injection combined with methotrexate for injection in the treatment of active rheumatoid arthritis[J]. World Clinical Drug, 2023 , 44 (3) : 258 -262 . DOI: 10.13683/j.wph.2023.03.010
Year 2023 volume 44 Issue 3
13
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.03.010
  • Receive Date:2022-09-28
  • Online Date:2026-11-18
  • Published:2023-03-10
Article Data
Affiliations
History
  • Received:2022-09-28
  • Revised:2023-01-12
Funding
Affiliations
    1.Department of Rheumatology and Immunology, the Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong Province, China
    2.Department of Rheumatology and Immunology, Gaomi People's Hospital, Weifang 261599, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.03.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT